Changes Ahead for Squamous NSCLC Care
Cleveland Clinic medical oncologist James Stevenson, MD, discusses the coming sea-change in lung cancer care at the 2016 OncLive State of the Science Summit on Metastatic Non-Small Cell Lung Cancer.
As soon as a year from now, look for a “completely different paradigm” in the care of squamous non-small cell lung cancer, says Cleveland Clinic medical oncologist James Stevenson, MD. Dr. Stevenson discussed his outlook in detail at the recent 2016 OncLive State of the Science Summit on Metastatic Non–Small Cell Lung Cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
What changes to expect? Immunotherapy moves to the frontline while chemotherapy shifts to a second-line treatment. Read the entire Q&A with Dr. Stevenson.